These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 25072937)

  • 1. Effect of arginase inhibition on ischemia-reperfusion injury in patients with coronary artery disease with and without diabetes mellitus.
    Kövamees O; Shemyakin A; Pernow J
    PLoS One; 2014; 9(7):e103260. PubMed ID: 25072937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Arginase inhibition improves endothelial function in patients with coronary artery disease and type 2 diabetes mellitus.
    Shemyakin A; Kövamees O; Rafnsson A; Böhm F; Svenarud P; Settergren M; Jung C; Pernow J
    Circulation; 2012 Dec; 126(25):2943-50. PubMed ID: 23183942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. L-arginine and tetrahydrobiopterin protects against ischemia/reperfusion-induced endothelial dysfunction in patients with type 2 diabetes mellitus and coronary artery disease.
    Settergren M; Böhm F; Malmström RE; Channon KM; Pernow J
    Atherosclerosis; 2009 May; 204(1):73-8. PubMed ID: 18849028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Arginase Inhibition Improves Microvascular Endothelial Function in Patients With Type 2 Diabetes Mellitus.
    Kövamees O; Shemyakin A; Checa A; Wheelock CE; Lundberg JO; Östenson CG; Pernow J
    J Clin Endocrinol Metab; 2016 Nov; 101(11):3952-3958. PubMed ID: 27399350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Local arginase inhibition during early reperfusion mediates cardioprotection via increased nitric oxide production.
    Gonon AT; Jung C; Katz A; Westerblad H; Shemyakin A; Sjöquist PO; Lundberg JO; Pernow J
    PLoS One; 2012; 7(7):e42038. PubMed ID: 22860052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ischemia-reperfusion selectively impairs nitric oxide-mediated dilation in coronary arterioles: counteracting role of arginase.
    Hein TW; Zhang C; Wang W; Chang CI; Thengchaisri N; Kuo L
    FASEB J; 2003 Dec; 17(15):2328-30. PubMed ID: 14563685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TNF-alpha contributes to endothelial dysfunction by upregulating arginase in ischemia/reperfusion injury.
    Gao X; Xu X; Belmadani S; Park Y; Tang Z; Feldman AM; Chilian WM; Zhang C
    Arterioscler Thromb Vasc Biol; 2007 Jun; 27(6):1269-75. PubMed ID: 17413034
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Arginase inhibition reduces infarct size via nitric oxide, protein kinase C epsilon and mitochondrial ATP-dependent K+ channels.
    Tratsiakovich Y; Gonon AT; Krook A; Yang J; Shemyakin A; Sjöquist PO; Pernow J
    Eur J Pharmacol; 2013 Jul; 712(1-3):16-21. PubMed ID: 23665492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic Co-Administration of Sepiapterin and L-Citrulline Ameliorates Diabetic Cardiomyopathy and Myocardial Ischemia/Reperfusion Injury in Obese Type 2 Diabetic Mice.
    Baumgardt SL; Paterson M; Leucker TM; Fang J; Zhang DX; Bosnjak ZJ; Warltier DC; Kersten JR; Ge ZD
    Circ Heart Fail; 2016 Jan; 9(1):e002424. PubMed ID: 26763290
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of Rho kinase protects from ischaemia-reperfusion injury via regulation of arginase activity and nitric oxide synthase in type 1 diabetes.
    Tratsiakovich Y; Kiss A; Gonon AT; Yang J; Sjöquist PO; Pernow J
    Diab Vasc Dis Res; 2017 May; 14(3):236-245. PubMed ID: 28183205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Arginase inhibition mediates cardioprotection during ischaemia-reperfusion.
    Jung C; Gonon AT; Sjöquist PO; Lundberg JO; Pernow J
    Cardiovasc Res; 2010 Jan; 85(1):147-54. PubMed ID: 19726439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Arginase inhibition improves endothelial function in patients with familial hypercholesterolaemia irrespective of their cholesterol levels.
    Kovamees O; Shemyakin A; Eriksson M; Angelin B; Pernow J
    J Intern Med; 2016 May; 279(5):477-84. PubMed ID: 26707366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Arginase inhibition improves coronary microvascular function and reduces infarct size following ischaemia-reperfusion in a rat model.
    Grönros J; Kiss A; Palmér M; Jung C; Berkowitz D; Pernow J
    Acta Physiol (Oxf); 2013 Jun; 208(2):172-9. PubMed ID: 23497275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amino acid metabolism reflecting arginase activity is increased in patients with type 2 diabetes and associated with endothelial dysfunction.
    Kövamees O; Shemyakin A; Pernow J
    Diab Vasc Dis Res; 2016 Sep; 13(5):354-60. PubMed ID: 27190086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. L-arginine protects from ischemia-reperfusion-induced endothelial dysfunction in humans in vivo.
    Pernow J; Bohm F; Beltran E; Gonon A
    J Appl Physiol (1985); 2003 Dec; 95(6):2218-22. PubMed ID: 12937030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. L-arginine: effect on reperfusion injury after heart transplantation.
    Szabó G; Bährle S; Bátkai S; Stumpf N; Dengler TJ; Zimmermann R; Vahl CF; Hagl S
    World J Surg; 1998 Aug; 22(8):791-7; discussion 797-8. PubMed ID: 9673548
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Arginase Inhibition Reverses Endothelial Dysfunction, Pulmonary Hypertension, and Vascular Stiffness in Transgenic Sickle Cell Mice.
    Steppan J; Tran HT; Bead VR; Oh YJ; Sikka G; Bivalacqua TJ; Burnett AL; Berkowitz DE; Santhanam L
    Anesth Analg; 2016 Sep; 123(3):652-8. PubMed ID: 27537757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rosuvastatin prevents conduit artery endothelial dysfunction induced by ischemia and reperfusion by a cyclooxygenase-2-dependent mechanism.
    Liuni A; Luca MC; Gori T; Parker JD
    J Am Coll Cardiol; 2010 Mar; 55(10):1002-6. PubMed ID: 20202516
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Arginase Inhibition Improves Endothelial Function in an Age-Dependent Manner in Healthy Elderly Humans.
    Mahdi A; Pernow J; Kövamees O
    Rejuvenation Res; 2019 Oct; 22(5):385-389. PubMed ID: 30526321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Arginase inhibition improves endothelial function in patients with type 2 diabetes mellitus despite intensive glucose-lowering therapy.
    Mahdi A; Kövamees O; Checa A; Wheelock CE; von Heijne M; Alvarsson M; Pernow J
    J Intern Med; 2018 Oct; 284(4):388-398. PubMed ID: 30151846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.